Hepatic safety of ambrisentan alone and in combination with tadalafil: a post-hoc analysis of the AMBITION trial

por Patel, Krishna R., Blair, Christiana J., Tislow, James D.
Publicado 2018

Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat popula...

por Kuwana, Masataka, Blair, Christiana, Takahashi, Tomohiko, Langley, Jonathan, Coghlan, John G
Publicado 2020

109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

por Andreatta, Kristen, D’Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2020

629. High Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in African American Adults with HIV Including Those with Preexisting Resistance, Viral Blips, and Su...

por Andreatta, Kristen, D'Antoni, Michelle L, Chang, Silvia, Parvangada, Aiyappa, Martin, Ross, Blair, Christiana, Collins, Sean E, White, Kirsten L
Publicado 2021

1046. Week 48 Outcomes from the BRAAVE 2020 Study: A Randomized Switch to B/F/TAF in African American Adults with HIV

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K, Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn, Ramgopal, Moti, McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E, Brainard, Diana M, Martin, Hal
Publicado 2020

Clinical outcomes stratified by baseline functional class after initial combination therapy for pulmonary arterial hypertension

por White, R. James, Vonk-Noordegraaf, Anton, Rosenkranz, Stephan, Oudiz, Ronald J., McLaughlin, Vallerie V., Hoeper, Marius M., Grünig, Ekkehard, Ghofrani, Hossein-Ardeschir, Chakinala, Murali M., Barberà, Joan A., Blair, Christiana, Langley, Jonathan, Frost, Adaani E.
Publicado 2019

Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study

por Hagins, Debbie, Kumar, Princy, Saag, Michael, Wurapa, Anson K., Brar, Indira, Berger, Daniel, Osiyemi, Olayemi, Hileman, Corrilynn O., Ramgopal, Moti N., McDonald, Cheryl, Blair, Christiana, Andreatta, Kristen, Collins, Sean E., Brainard, Diana M., Martin, Hal
Publicado 2021

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years...

por Maggiolo, Franco, Rizzardini, Giuliano, Molina, Jean‐Michel, Pulido, Federico, De Wit, Stephane, Vandekerckhove, Linos, Berenguer, Juan, D'Antoni, Michelle L., Blair, Christiana, Chuck, Susan K., Piontkowsky, David, Martin, Hal, Haubrich, Richard, McNicholl, Ian R., Gallant, Joel
Publicado 2022

1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Diseas...

por Eron, Joseph J, Wilkin, Aimee, Ramgopal, Moti, Osiyemi, Olayemi, McKellar, Mehri, McKellar, Mehri, Slim, Jihad, Asmuth, David, DeJesus, Edwin, German, Polina, Blair, Christiana, Carter, Christoph C, Brainard, Diana M, Collins, Sean E, Martin, Hal
Publicado 2020

Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People with HIV Aged ≥ 65 Years: Week 48 Results of a Phase 3b, Open-Label Trial

por Maggiolo, Franco, Rizzardini, Giuliano, Molina, Jean-Michel, Pulido, Federico, De Wit, Stephane, Vandekerckhove, Linos, Berenguer, Juan, D’Antoni, Michelle L., Blair, Christiana, Chuck, Susan K., Piontkowsky, David, Martin, Hal, Haubrich, Richard, McNicholl, Ian R., Gallant, Joel
Publicado 2021

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

por Sax, Paul E., Andreatta, Kristen, Molina, Jean-Michel, Daar, Eric S., Hagins, Debbie, Acosta, Rima, D’Antoni, Michelle L., Chang, Silvia, Martin, Ross, Liu, Hui, Blair, Christiana, McNicholl, Ian, Gallant, Joel, Collins, Sean E., Martin, Hal, White, Kirsten L.
Publicado 2022

2490. Longer-Term Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed Adults Living With HIV and End-Stage Renal Disease...

por Eron, Joseph J, Lelievre, Jean-Daniel, Kalayjian, Robert, Slim, Jihad, Wurapa, Anson K, Stephens, Jeffrey L, McDonald, Cheryl, Cua, Eric, Wilkin, Arjun, McKellar, Mehri, Cox, Stephanie, Majeed, Sophia, Blair, Christiana, Carter, Christoph C, SenGupta, Devi, Brainard, Diana M, Das, Moupali
Publicado 2019

Initial combination therapy with ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH): subgroup analysis from the AMBITION tr...

por Coghlan, John Gerry, Galiè, Nazzareno, Barberà, Joan Albert, Frost, Adaani E, Ghofrani, Hossein-Ardeschir, Hoeper, Marius M, Kuwana, Masataka, McLaughlin, Vallerie V, Peacock, Andrew J, Simonneau, Gérald, Vachiéry, Jean-Luc, Blair, Christiana, Gillies, Hunter, Miller, Karen L, Harris, Julia H N, Langley, Jonathan, Rubin, Lewis J
Publicado 2017

Characterization of Ebola Virus Disease (EVD) in Rhesus Monkeys for Development of EVD Therapeutics

por Warren, Travis, Zumbrun, Elizabeth, Weidner, Jessica M., Gomba, Laura, Rossi, Franco, Bannister, Roy, Tarrant, Jacqueline, Reed, Matthew, Lee, Eric, Raymond, Jo Lynne, Wells, Jay, Shamblin, Joshua, Wetzel, Kelly, Donnelly, Ginger, Van Tongeren, Sean, Lackemeyer, Nicole, Steffens, Jesse, Kimmel, Adrienne, Garvey, Carly, Bloomfield, Holly, Blair, Christiana, Singh, Bali, Bavari, Sina, Cihlar, Tomas, Porter, Danielle
Publicado 2020

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

por Goldman, Jason D., Lye, David C.B., Hui, David S., Marks, Kristen M., Bruno, Raffaele, Montejano, Rocio, Spinner, Christoph D., Galli, Massimo, Ahn, Mi-Young, Nahass, Ronald G., Chen, Yao-Shen, SenGupta, Devi, Hyland, Robert H., Osinusi, Anu O., Cao, Huyen, Blair, Christiana, Wei, Xuelian, Gaggar, Anuj, Brainard, Diana M., Towner, William J., Muñoz, Jose, Mullane, Kathleen M., Marty, Francisco M., Tashima, Karen T., Diaz, George, Subramanian, Aruna
Publicado 2020

73. Geographical Disparities in Clinical Outcomes of Severe COVID-19 Patients Treated with Remdesivir

por Diaz, George, Arribas, Jose Ramon, Arribas, Jose Ramon, Robinson, Philip A, Cattelan, Anna Maria, Tashima, Karen T, Tsang, Owen Tak-Yin, Tsang, Owen Tak-Yin, Chen, Yao-Shen, Chen, Yao-Shen, SenGupta, Devi, Vendrame, Elena, Blair, Christiana, Chokkalingam, Anand, Osinusi, Anu, Brainard, Diana M, Chin, Bum Sik, Chin, Bum Sik, Spinner, Christoph, Criner, Gerard J, Criner, Gerard J, Muñoz, Jose, Lye, David Chien Boon, Lye, David Chien Boon, Gottlieb, Robert L
Publicado 2020